The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 02, 2021
Filed:
Mar. 31, 2017
Applicant:
Public University Corporation Nagoya City University, Nagoya, JP;
Inventors:
Yasuhito Tanaka, Nagoya, JP;
Kentaro Matsuura, Nagoya, JP;
Assignee:
PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, Nagoya, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); C12N 15/09 (2006.01); G01N 33/53 (2006.01); G01N 33/68 (2006.01); C12Q 1/68 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12N 15/09 (2013.01); C12Q 1/68 (2013.01); G01N 33/50 (2013.01); G01N 33/53 (2013.01); G01N 33/68 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01);
Abstract
The present invention addresses the problem of how to provide a predictive marker useful for carcinogenesis surveillance after hepatitis C virus eradication. Provided is a predictive marker composed of a single nucleotide polymorphism specified by rs17047200. In the present invention, the single nucleotide polymorphism is detected in nucleic acid samples collected from subjects, thereby to examine the risk of developing hepatocellular carcinoma after of hepatitis C virus eradication.